Related Experiment Video
Updated: Jun 3, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Metabolic bone disease of prematurity and secondary hyperparathyroidism
Ashish Lothe1, John Sinn, Monique Stone
1Department of Neonatology, Royal North Shore Hospital The University of Sydney, Sydney, New South Wales, Australia.
Insights
Early diagnosis of metabolic bone disease (MBD) in premature infants is crucial. Laboratory tests like alkaline phosphatase and parathyroid hormone (PTH) aid in managing MBD, even with normal calcium and phosphate levels.
Area of Science:
- Neonatology
- Pediatric Endocrinology
- Biochemistry
Background:
- Metabolic bone disease (MBD) poses a significant risk to extremely premature infants.
- Prematurity, low birth weight, and feeding intolerance are key risk factors for MBD.
Observation:
- Three cases of extreme premature infants with MBD are presented.
- Risk factors included very low birth weight, delayed enteral feeds, cholestatic liver disease, and medication use.
- Elevated serum alkaline phosphatase and parathyroid hormone (PTH) were noted despite normal calcium and phosphate levels.
Findings:
- MBD in premature infants leads to significant calcium and phosphate depletion.
- Normal serum calcium and phosphate may mask inadequate intake or stores due to PTH.
- Supplementation with calcium, phosphate, and vitamin D corrected MBD parameters.
Implications:
- Routine laboratory monitoring of alkaline phosphatase, vitamin D, and PTH is recommended for at-risk infants.
- Early diagnosis and management of MBD are essential for optimal infant outcomes.
- Understanding the role of PTH in masking MBD is critical for clinical practice.
Aim:
To illustrate, via case histories, the importance of laboratory investigations for the early diagnosis and management of metabolic bone disease (MBD).
Methods:
We report three cases of extreme premature infants with MBD.
Results:
These three infants had several risk factors for MBD of prematurity: very low birthweight, delayed enteral feeds, cholestatic liver disease, intolerance of fortification, the use of glucocorticoids and diuretics. Serum alkaline phosphatase and parathyroid hormone (PTH) were elevated despite relatively normal calcium and phosphate levels. These parameters were corrected with additional supplementation of calcium, phosphate and vitamin D.
Conclusions:
Infants born extremely prematurely have significant calcium and phosphate depletion by the time they reach full term compared with the normal fetal accretion rate. This is exacerbated if there is poor tolerability to feeds where extra calcium and phosphate could not be added either by additives or via human milk fortifier. Serum calcium and phosphate levels may be normal despite inadequate intake or stores due to the counter-regulatory effect of PTH. In infants at risk of MBD, testing serum alkaline phosphatase, vitamin D and PTH with calcium and phosphate may assist in the monitoring and management of MBD.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hyperthyroidism II: Pathophysiology
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Graves Disease II: Pathophysiology
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
